These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 7681990)

  • 21. Distinct antigenic features of linear epitopes at the N-terminus and C-terminus of 65 kDa glutamic acid decarboxylase (GAD65): implications for autoantigen modification during pathogenesis.
    Al-Bukhari TA; Radford PM; Bouras G; Davenport C; Trigwell SM; Bottazzo GF; Lai M; Schwartz HL; Tighe PJ; Todd I
    Clin Exp Immunol; 2002 Oct; 130(1):131-9. PubMed ID: 12296864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical differentiation of monoclonal GAD antibodies recognizing linear or conformational epitope regions.
    Augstein P; Ziegler B; Schlosser M; Flassig S; Strebelow M; Ziegler M
    Pancreas; 1997 Aug; 15(2):139-46. PubMed ID: 9260198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes.
    Schlosser M; Banga JP; Madec AM; Binder KA; Strebelow M; Rjasanowski I; Wassmuth R; Gilliam LK; Luo D; Hampe CS
    Diabetologia; 2005 May; 48(5):922-30. PubMed ID: 15834701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two amino acids in glutamic acid decarboxylase act in concert for maintenance of conformational determinants recognised by Type I diabetic autoantibodies.
    Tree TI; Morgenthaler NG; Duhindan N; Hicks KE; Madec AM; Scherbaum WA; Banga JP
    Diabetologia; 2000 Jul; 43(7):881-9. PubMed ID: 10952461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome.
    Butler MH; Solimena M; Dirkx R; Hayday A; De Camilli P
    J Exp Med; 1993 Dec; 178(6):2097-106. PubMed ID: 8245784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes.
    Hampe CS; Hammerle LP; Bekris L; Ortqvist E; Kockum I; Rolandsson O; Landin-Olsson M; Törn C; Persson B; Lernmark A
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4671-9. PubMed ID: 11134126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantigenic reactivity of diabetes sera with a hybrid glutamic acid decarboxylase GAD67-65 molecule GAD67(1-101)/GAD65(96-585).
    Teoh KL; Fida S; Rowley MJ; Mackay IR
    Autoimmunity; 1998; 28(4):259-66. PubMed ID: 9892508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two distinct glutamic acid decarboxylase auto-antibody specificities in IDDM target different epitopes.
    Daw K; Powers AC
    Diabetes; 1995 Feb; 44(2):216-20. PubMed ID: 7532143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes.
    Björk E; Velloso LA; Kämpe O; Karlsson FA
    Diabetes; 1994 Jan; 43(1):161-5. PubMed ID: 7505244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A diabetes-related epitope of GAD65: a major diabetes-related conformational epitope on GAD65.
    Myers MA; Fenalti G; Gray R; Scealy M; Tong JC; El-Kabbani O; Rowley MJ
    Ann N Y Acad Sci; 2003 Nov; 1005():250-2. PubMed ID: 14679070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes.
    Kobayashi T; Tanaka S; Okubo M; Nakanishi K; Murase T; Lernmark A
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4768-75. PubMed ID: 14557453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome.
    Richter W; Seissler J; Northemann W; Wolfahrt S; Meinck HM; Scherbaum WA
    Diabetes; 1993 Nov; 42(11):1642-8. PubMed ID: 8405707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The PEVKEK region of the pyridoxal phosphate binding domain of GAD65 expresses a dominant B cell epitope for type 1 diabetes sera.
    Tong JC; Myers MA; Mackay IR; Zimmet PZ; Rowley MJ
    Ann N Y Acad Sci; 2002 Apr; 958():182-9. PubMed ID: 12021103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
    Seissler J; Amann J; Mauch L; Haubruck H; Wolfahrt S; Bieg S; Richter W; Holl R; Heinze E; Northemann W
    J Clin Invest; 1993 Sep; 92(3):1394-9. PubMed ID: 8376591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequence homology of the diabetes-associated autoantigen glutamate decarboxylase with coxsackie B4-2C protein and heat shock protein 60 mediates no molecular mimicry of autoantibodies.
    Richter W; Mertens T; Schoel B; Muir P; Ritzkowsky A; Scherbaum WA; Boehm BO
    J Exp Med; 1994 Aug; 180(2):721-6. PubMed ID: 7913951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GAD65 as a prototypic autoantigen.
    Fenalti G; Rowley MJ
    J Autoimmun; 2008 Nov; 31(3):228-32. PubMed ID: 18514483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characterization of a disease associated conformational epitope on GAD65 recognised by a human monoclonal antibody b96.11.
    Fenalti G; Hampe CS; O'connor K; Banga JP; Mackay IR; Rowley MJ; El-Kabbani O
    Mol Immunol; 2007 Feb; 44(6):1178-89. PubMed ID: 16930708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibodies specific to the glutamic acid decarboxylase 65 kDa isoform derived from a non-obese diabetic (NOD) mouse.
    Ziegler B; Augstein P; Lühder F; Northemann W; Hamann J; Schlosser M; Klöting I; Michaelis D; Ziegler M
    Diabetes Res; 1994; 25(2):47-64. PubMed ID: 7544254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epitope spreading and a varying but not disease-specific GAD65 antibody response in Type I diabetes. The Childhood Diabetes in Finland Study Group.
    Söhnlein P; Müller M; Syren K; Hartmann U; Böhm BO; Meinck HM; Knip M; Akerblom HK; Richter W
    Diabetologia; 2000 Feb; 43(2):210-7. PubMed ID: 10753043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant Fabs of human monoclonal antibodies specific to the middle epitope of GAD65 inhibit type 1 diabetes-specific GAD65Abs.
    Padoa CJ; Banga JP; Madec AM; Ziegler M; Schlosser M; Ortqvist E; Kockum I; Palmer J; Rolandsson O; Binder KA; Foote J; Luo D; Hampe CS
    Diabetes; 2003 Nov; 52(11):2689-95. PubMed ID: 14578287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.